September 15-17, 2022 |
View our poster at the 4th iteration of the EASL NAFLD Summit
- NASH PASS®: a registry to inform study design and accelerate patient enrollment
- Authors: A. Macias, H. Guthrie, M. Mazuranic, and M. Hompesch
- Poster number: P07-04
Meet with the ProSciento team of experts to learn about how our unparalleled NAFLD and NASH trial experience, proven, science-driven strategies, and specialized services benefit you, while also advancing research in biomarker discovery and disease progression.
Benefits of working with ProSciento:
- More than 12 years of experience designing and conducting NAFLD and NASH clinical trials
- Leading provider: more early phase NAFLD and NASH clinical trials conducted than any other U.S.-based provider
- More than 4,500 prescreened patients at-risk for NAFLD and NASH ready for your clinical trials
View conference website
